Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Deep Origin today posted a comprehensive preprint on bioRxiv describing a major advance in virtual screening.
-
REDMOND, Wash., July 27, 2026 (GLOBE NEWSWIRE) -- Pattern Computer®, Inc. (“Pattern” or “the Company”), the global leader in Pattern Discovery, today announced the appointment of Sir Richard B....
-
Pluristyx partners with WFIRM, Innovian Space & ReMDO to scale clinical-grade hepatocyte manufacturing for terrestrial and LEO space bioengineering.
-
Translational and clinical data reinforce IMNN-001's potential to unlock IL-12's anti-tumor power in ovarian cancer within a highly safe, proprietary mechanism First-of-its-kind meeting spotlights...
-
Enterome Phase 2 data show EO2463-induced CD8 T-cell expansion correlates with PFS in patients with iNHL in the watch-and-wait setting
-
Deep Origin today announced that its computational platform contributed to a peer-reviewed study published in Cell.
-
From 647 nominations globally, Hummingbird Bioscience emerged as a winner, recognizing the company’s AI-first approach to drug discovery and development.
-
Dublin, July 13, 2026 (GLOBE NEWSWIRE) -- The "Pharmaceutical Regulatory Affairs in the Middle East and North Africa (Oct 20th - Oct 22nd, 2026)" has been added to ResearchAndMarkets.com's...
-
Certara partners with NVIDIA to advance its open, integrated AI platform for drug discovery and development with the BioNeMo Agent Toolkit
-
Dublin, July 06, 2026 (GLOBE NEWSWIRE) -- The "Pharmaceutical Regulatory Affairs in Asia (Oct 20th - Oct 22nd, 2026)" has been added to ResearchAndMarkets.com's offering. The course addresses a...